Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes With Chronic Kidney Disease”

211 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 211 results

Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Large-scale testing (Phase 3)WithdrawnNCT02015780
What this trial is testing

Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease
Takeda
Testing effectiveness (Phase 2)Study completedNCT01847092
What this trial is testing

A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes Mellitus
Ardelyx 154
Not applicableUnknownNCT05847400
What this trial is testing

Predictors of Chronic Kidney Disease Among Type 2 Diabetic Patients in Assiut University Hospitals

Who this might be right for
Type 2 Diabetes With Renal Manifestations
Assiut University 200
Post-approval studies (Phase 4)Study completedNCT03226457
What this trial is testing

SGLT2 Inhibition in Combination With Diuretics in Heart Failure

Who this might be right for
Heart FailureType 2 Diabetes Mellitus
University of Dundee 23
Not applicableStudy completedNCT04791267
What this trial is testing

ENCOMPASS: Expansion Study C

Who this might be right for
HypertensionDiabetes Mellitus, Type 2Chronic Kidney Diseases+4 more
University of Calgary 61
Testing effectiveness (Phase 2)Study completedNCT01213212
What this trial is testing

Preventing Renal Functional Abnormalities With Calorie Restriction in Subjects With Abdominal Obesity and Type 2 Diabetes at Increased Renal and Cardiovascular Risk

Who this might be right for
Diabetes Mellitus
Mario Negri Institute for Pharmacological Research 73
Large-scale testing (Phase 3)Study completedNCT00509236
What this trial is testing

Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1)

Who this might be right for
Diabetes Mellitus, Type 2End-Stage Kidney Disease
Merck Sharp & Dohme LLC 129
Not applicableLooking for participantsNCT03549754
What this trial is testing

ICaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases

Who this might be right for
Type 2 DiabetesHypertensionChronic Kidney Disease+1 more
AstraZeneca 35,000
Not applicableStudy completedNCT05552339
What this trial is testing

A Study Called SMART-Finder to Look for People With Increased Amounts of Albumin in the Urine (UACR Level) in a Group of Type 2 Diabetes Mellitus Patients

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease
Bayer 348
Post-approval studies (Phase 4)Study completedNCT01617824
What this trial is testing

Rapid Effects Linagliptin on Monocyte Polarization and Endothelial Progenitor Cells in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesChronic Renal Failure
University of Padova 45
Not applicableUnknownNCT04799925
What this trial is testing

Hyperuricemia and Diabetic Nephropathy

Who this might be right for
HyperuricemiaDiabetic Nephropathies
Assiut University 200
Testing effectiveness (Phase 2)Study completedNCT04515849
What this trial is testing

Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Diseases
AstraZeneca 248
Early research (Phase 1)Study completedNCT01407276
What this trial is testing

Omarigliptin (MK-3102) in Participants With Impaired Renal Function (MK-3102-009)

Who this might be right for
Chronic Renal InsufficiencyType 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 49
Not applicableUnknownNCT04058951
What this trial is testing

Plant Versus Animal Dietary Protein and the Effect on Proteinuria

Who this might be right for
Kidney InsufficiencyDiabetes MellitusDiabetes Mellitus, Type 2+6 more
Jens Rikardt Andersen 20
Early research (Phase 1)Study completedNCT00418366
What this trial is testing

A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)

Who this might be right for
Renal InsufficiencyHemodialysis
Merck Sharp & Dohme LLC 24
Early research (Phase 1)WithdrawnNCT01551446
What this trial is testing

Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes

Who this might be right for
Renal Insufficiency, ChronicDiabetes Mellitus, Type 2
Biogen
Testing effectiveness (Phase 2)Study completedNCT00421733
What this trial is testing

The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors

Who this might be right for
Diabetic NephropathyChronic Kidney Disease
Abbott 281
Not applicableLooking for participantsNCT04802395
What this trial is testing

Real World Evidence Clinical Utility Study of KidneyIntelX

Who this might be right for
Chronic Kidney DiseasesDiabetic Kidney Disease
Renalytix AI, Inc. 10,000
Not applicableActive Not RecruitingNCT05198284
What this trial is testing

Prospective Decision Impact Clinical Utility Trial of KidneyIntelX

Who this might be right for
Diabetic Kidney DiseaseChronic Kidney DiseasesChronic Kidney Disease Stage 1+2 more
Renalytix AI, Inc. 2,000
Next Page